Info

Oncotherapeutics is a full service Contract Research Organization (CRO) with a unique focus on the therapeutic oncology area. This specialized approach offers a strategic advantage to our clients in the pharmaceutical, biotechnology and device industries. With expertise in phase I-IV clinical trials and pharmacokinetic studies, we offer a wide array of services that are custom tailored to meet your needs. Our comprehensive program encompasses laboratory research, protocol concept, design and development, clinical trial management, monitoring, data management, biostatistics, safety review, clinical and database auditing, medical monitoring and medical writing. Nationally recognized research oncologists and key opinion leaders in the oncology field oversee senior level clinical research teams. We completely plan, conduct, execute, validate, analyze, prepare and finalize clinical study reports for submission. Oncotherapeutics has successfully conducted a multitude of oncology studies in the areas of multiple myeloma, myelodysplastic syndrome, monoclonal gammopathy of undetermined significance (MGUS), melanoma, non-small cell lung cancer (NSCLC), breakthrough cancer pain, other hematologic malignancies, and metastatic bone disease. Our proven track record of client satisfaction and success is a testament to our commitment to the highest standards of innovation, support and return on investment. We look forward to helping you achieve your goals.